Literature DB >> 8464987

Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection.

I Merican1, S Sherlock, N McIntyre, G M Dusheiko.   

Abstract

The clinical, biochemical and histological features of 102 consecutively referred patients with chronic hepatitis C virus infection were analysed. Demographic, epidemiological, biochemical, haematological and histological details were catalogued for each patient. The mean follow-up was 49 +/- 6 months. Liver biopsies were obtained from 92 patients; a second biopsy was obtained from 35 patients. The average known duration of infection was 8.6 +/- 0.7 years. The most common risk factors that could be identified were past blood transfusion, surgery or intravenous drug abuse. Twenty-four of the 27 patients (85%) with past blood transfusion had received blood in countries outside of northern Europe. In contrast, 12 of the 16 former drug users were northern European. Patients were frequently diagnosed incidentally; one-quarter had no symptoms of liver disease and were generally asymptomatic or had presented with non-specific complaints and were found to have abnormal serum aminotransferase levels after routine screening. The mean serum aminotransferase levels were not significantly different in those presenting with fatigue compared to those diagnosed incidentally. The most common physical sign in these patients was a palpable liver, which was present in 52%. The mean serum albumin concentration in patients older than 40 years was significantly lower than that in younger patients. Splenomegaly and endoscopic evidence of varices was also more common in older patients. Cirrhosis was present in 37% of patients at presentation: 20% showed progression on rebiopsy, and 5% developed cirrhosis within 4 years of initial presentation. Of those treated, 27% showed histological improvement. Histological severity did not correlate with duration of disease, but did correlate with age.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8464987

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  7 in total

Review 1.  Human Immunoglobulins for intravenous use and hepatitis C viral transmission.

Authors:  H B Slade
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

2.  Hepatitis C virus: epidemiology and genotypes in the north east of England.

Authors:  J P Watson; A M Brind; C E Chapman; C L Bates; F K Gould; S J Johnson; A D Burt; J Ferguson; P Simmonds; M F Bassendine
Journal:  Gut       Date:  1996-02       Impact factor: 23.059

3.  Fatigue in primary biliary cirrhosis.

Authors:  K Cauch-Dudek; S Abbey; D E Stewart; E J Heathcote
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

4.  Assessment of fatigue in patients with chronic hepatitis C using the Fatigue Impact Scale.

Authors:  Ziad Hassoun; Bernard Willems; Julie Deslauriers; Bich Ngoc Nguyen; Pierre-Michel Huet
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

Review 5.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

Review 6.  Chronic hepatitis C in the aged: much ado about nothing or nothing to do?

Authors:  Stephen Malnick; Yaakov Maor; Ehud Melzer; Sari Tal
Journal:  Drugs Aging       Date:  2014-05       Impact factor: 3.923

7.  A practical approach to managing patients with HCV infection.

Authors:  Richard H Huang; Ke-Qin Hu
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.